Condensed Balance Sheets - USD ($)	Jun. 30, 2022	Dec. 31, 2021
Current Assets
Cash and Cash Equivalents	$ 6,416	$ 21,799
Prepaid and other current assets	14,206	5,000
Total current assets	20,622	26,799
Patents, net	38,475	0
TOTAL ASSETS	59,097	26,799
Current Liabilities
Accounts payable and accrued expenses	1,264,134	826,486
Accrued liabilities - related parties	22,651	3,207
Accrued litigation settlement	400,000	120,000
Promissory note payable	63,739	0
Loans payable - related parties	602,275	219,000
Total current liabilities	2,352,799	1,168,693
TOTAL LIABILITIES	2,352,799	1,168,693
Commitments and Contingencies	0	0
Stockholders' Equity (Deficit)
Series A Convertible Preferred Stock - $0.001 par value, 1,000,000 shares Authorized and 0 shares issued and outstanding	0	0
Common Stock - $0.001 par value, 300,000,000 shares Authorized, 229,877,509 and 228,667,229 shares issued at June 30, 2022 and December 31, 2021	229,877	228,667
Additional Paid-In Capital	71,708,164	71,017,881
Accumulated Deficit	(74,231,743)	(72,388,442)
Total Stockholders' Equity (Deficit)	(2,293,702)	(1,141,894)
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)	$ 59,097	$ 26,799